Elm3 Financial Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Elm3 Financial Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Sell	2,393 -65	-3%	-$6.73K	0.18%	114
2026 Q1	$255K	Buy	2,458 +10	+0.4%	+$1.06K	0.22%	99
2025 Q4	$253K	Buy	+2,448	New	+$238K	0.21%	99
2025 Q3	–	Sell	-2,439	Closed	-$215K	–	114
2025 Q2	$215K	Sell	2,439 -691	-22%	-$59.9K	0.18%	103
2025 Q1	$285K	Sell	3,130 -622	-17%	-$56K	0.25%	81
2024 Q4	$324K	Buy	+3,752	New	+$339K	0.28%	67

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Elm3 Financial Group's PPH Position: Q2 2026 in Review

Elm3 Financial Group reduced its VanEck Pharmaceutical ETF (PPH) stake by 2.6% in Q2 2026, selling an estimated $6.73K and leaving 2,393 shares worth $262K. The position accounts for 0.18% of the portfolio, ranked #114.

Elm3 Financial Group first reported a position in PPH in Q4 2024 and has held it in 6 quarters since. The position peaked at $324K in Q4 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Elm3 Financial Group held 2,393 shares of VanEck Pharmaceutical ETF worth $262K as of Q2 2026.
Elm3 Financial Group sold 65 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $6.73K.
VanEck Pharmaceutical ETF made up 0.18% of Elm3 Financial Group's portfolio in Q2 2026, its #114 holding.
Elm3 Financial Group first reported a position in VanEck Pharmaceutical ETF in Q4 2024 and has held it in 6 quarters since.
Elm3 Financial Group's VanEck Pharmaceutical ETF position peaked at $324K in Q4 2024.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Elm3 Financial Group's 13F filing for Q2 2026, filed 29 Jul 2026.